Investment Focus

Attention: open in a new window. PDFPrintE-mail

P.U.L.S. Investment Strategy

P.U.L.S. acts as an incubator and builds partnerships with innovators by providing top competence through the whole value chain. P.U.L.S. also facilitates financing of life science projects. And P.U.L.S. engages early, preferably at project start to support the scientific development, IP and business plan. The focus is on exit right from the start. Our geographic reach is primarily Sweden and the Nordic region. P.U.L.S.’s principle task is to provide the highest possible return on investment (of time and money) for the benefit of stakeholders.

Business area

Life science projects where the product under development aims to cure, treat or prevent a human disease.

  • Primary focus on medicinal products
  • Secondary focus on medical devices which can be developed into products.

Projects should be able to show:

  • Clear technological and competitive edge
  • Focus on defined patient population and medical need
  • Sufficiently large market or  significant niche potential
  • Proof-of-Principle data for medical or marketing claims